Blog
My Top Renewable Energy Stock to Buy in March
Shares of wind blade manufacturer TPI Composites (NASDAQ: TPIC) got walloped over the past week because Wall Street didn't like its 2021 guidance. The earnings report, paired with a broad market
Restaurant Brands Pits Burger King Against Popeyes in Chicken Sandwich Wars
At this point in the chicken sandwich wars, a fast-food chain needs to have its own version just to remain relevant even if it doesn't really move the needle on sales. Any announcement that a new
Why Early Retirees Shouldn't Worry Too Much About the Stock Market
Deciding to retire early can be a gut-wrenching decision. On one hand, you have the freedom, the possibilities, and the life of your dreams waiting in the wings. On the other, there's the potential
The Simple Reason to Avoid DoorDash Stock
The COVID-19 pandemic has been a boon for third-party restaurant delivery companies like DoorDash (NYSE: DASH). Dine-in restrictions have forced many restaurants to turn to delivery services to stay
Simon Property Group's SPAC Could Be Worth a Look
Investing in any special purpose acquisition company, or SPAC, that hasn't yet identified a target to take public is essentially a bet on management. That's why Fool.com contributor Matt Frankel
This Hot Growth Stock Could Soar Higher After Defying the Market Crash
Technology stocks have been hammered lately thanks to concerns about their potential overvaluation, but that hasn't affected memory specialist Micron Technology's (NASDAQ: MU) impressive run.
3 Best Marijuana Stocks to Buy in March
There are now 15 states (plus Washington, D.C.) that have legalized recreational marijuana, creating a wild west of opportunities for large dispensary chains and individual growers alike. In
3 Top Cybersecurity Stocks to Buy in March
If 2020 taught us anything, it's that the need for digital security has never been greater. The headlines are rife with details of the latest hack, intrusion, or attack. The methods used to gain
Dada Nexus Limited (DADA) Q4 2020 Earnings Call Transcript
Image source: The Motley Fool.
Dada Nexus Limited (NASDAQ: DADA)Q4 2020 Earnings CallMar 08, 2021, 8:00 p.m. ET
Operator
Source Fool.com
If You Invested $1,000 in Costco's IPO, This Is How Much Money You'd Have Now
Did you miss out on an amazing opportunity if you passed on investing in Costco Wholesale's (NASDAQ: COST) IPO? Probably, but it doesn't matter. Costco has a differentiated and strong business, and
5 Surprising Numbers From Cronos' Q4 Earnings Report
Cronos Group (NASDAQ: CRON) released its fourth-quarter results on Feb. 26 for the period ending Dec. 31, 2020. The cannabis producer had some mixed results; it generated sales growth, but losses
3 Reasons Cresco Labs Stock Will Light Up Your Portfolio
Cannabis stocks have had a rough couple of years. The sector's benchmark fund, the Horizons Marijuana Life Sciences ETF, spent most of 2019 and early 2020 sinking, and that period was followed by
Sundial Growers' Price Target Just Jumped 20% -- but There's a Catch
Few industries are hotter right now than marijuana. According to analytics firm New Frontier Data, weed sales in the U.S., the largest cannabis market in the world, could triple to as much as $41.5
Got $1,000 to Invest? Here's How to Turn It Into $45,000 With Zero Effort
It's easy to fall into the trap of thinking that in order to become wealthy in the stock market, you have to have a lot of money to invest.
However, you don't need to be rich to be a successful
Could Novavax Be a Millionaire-Maker Stock?
If you invested $10,000 in Novavax (NASDAQ: NVAX) last March, that principal would be worth nearly $133,000 just one year later. But over the past month or so, Novavax stock has fallen nearly 45%
3 Small-Cap Stocks With Big-Cap Potential
With the way the stock market has performed over the past year or so, especially when it comes to fast-growing companies, it has become far more difficult to find small-cap stocks worth investing
2 Top Stocks to Buy in March
March is shaping up to be an exciting month for investors. COVID-19 vaccinations are ramping up, which means hope for a pandemic-weary world. Walt Disney (NYSE: DIS) and Six Flags Entertainment
1 Big Risk of SPAC Investing
A big investor safety net when it comes to SPAC investing is that if the "blank check" company isn't able to find an acquisition target, investors get their money back.
Well, sort of. Many SPACs
Why Investors Shouldn't Get Too Excited About Canopy Growth's Latest Move
Cannabis investors have grown accustomed to splashy, exciting announcements by companies in the sector. But sometimes, a well written press release makes much more of the announcement than what it
Warren Buffett Just Bought These 3 High-Yield Dividend Stocks. Should You?
Warren Buffett's Berkshire Hathaway (NYSE: BRKA) (NYSE: BRKB) has never paid a dividend. But make no mistake about it: The billionaire investor really likes dividends. In fact, he highlighted the
British American Tobacco Lost Nothing By Waiting to Enter the Marijuana Market
Tobacco companies have been interested in marijuana for decades, but only recently have cigarette producers made serious investments in the industry.
While that's due to a combination of declining
Adding $1,000 to These 3 Stocks Would Be a Brilliant Move Right Now
Do the smartest investors run for the hills when the market pulls back? Absolutely not. Instead, they capitalize on the opportunity to add to their positions in great stocks at more attractive
3 Penny Stocks That Can Double Your $1,400 Stimulus Check
Following more than a month of back-and-forth debates on Capitol Hill, the finishing touches are being placed on the next round of fiscal stimulus. President Joe Biden is expected to sign the $1.9
Planning to Claim Social Security at 65? You May Need to Rethink That
When it comes to signing up for Social Security, you have a number of options. You can file for benefits as early as age 62 (albeit in exchange for a reduced payment), wait until your full
This Warning From the CEO of the World's Biggest Vaccine Maker Could Be Bad News for Novavax
Pretty much everything seems to be going as hoped for Novavax (NASDAQ: NVAX) these days. The company reported great interim results from a U.K. late-stage study of its COVID-19 vaccine NVX-CoV2373


